与间歇性肺部疾病相关的风湿性疾病:在二级护理环境中的现实结果
Alex Francioni1, Muhammad K Nisar2, Natasha Ramsundar1
1Respiratory Department, Luton and Dunstable University Hospital NHSFT, Luton.
概括
带有间歇性肺病 (r-ILD) 的风湿病可以在地区总医院有效地在当地管理. 这项试点研究显示了良好的临床结果,改善了患者体验,并支持了三级医疗保健.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 临床医学 临床医学
背景情况:
- 与间歇性肺病 (r-ILD) 相关的类风湿病的管理通常需要在三级中心提供专门的护理.
- 这往往导致长时间的患者旅程,并可能影响患者的体验.
研究的目的:
- 建立和评估一个地区总医院 (DGH) 内的r-ILD患者的结合性风湿病和呼吸系统服务.
- 评估当地r-ILD管理的可行性和临床结果,旨在减少对第三级转诊的依赖.
主要方法:
- 在DGH建立了一个试点综合性风湿病和呼吸道诊所.
- 转诊者通过每月的间歇性肺病 (ILD) 多学科团队会议进行了分类.
- 关于人口统计,疾病参数,调查和药物管理的数据被电子收集了104名患者.
主要成果:
- 51%的患者表现出稳定或改善的症状,67%的CT成像表现稳定或改善.
- 肺功能测试,包括强迫生命能力 (78%) 和肺部对一氧化碳的扩散能力 (77%),显示稳定或改善.
- 在6分钟步行测试中观察到类似的改善,表明了积极的功能结果.
结论:
- 与间歇性肺部疾病相关的风湿性疾病可以在DGH环境中成功管理,实现与专业中心相似的临床结果.
- 建立地方的r-ILD服务可以减轻对过度紧张的第三级护理的压力,并培养当地专业知识.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Secondary Healthcare System
1.4K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.4K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pleural Effusion II: Symptoms and Management
135
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
135
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144


